Infusion-Related Reactions With Ocrelizumab: Risk Factors, Symptom Management and Patient Choices in the ENSEMBLE PLUS StudyRobert Bermel,Joep Killestein,Thomas Berger,Bruno Brochet,William Carroll,Mark Freedman,Trygve Holmoy,Rana Karabudak,Carlos Nos, Francesco Patti,Amy Perrin Ross,Ludo Vanopdenbosch,Timothy Vollmer,Regine Buffels,Karen Kadner,Oscar Bortolami,Hans-Peter HartungNEUROLOGY(2023)引用 0|浏览20暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要